Back to search
FDAFDA · Food and drugs·Recall number D-1173-2016

B-COMPLEX 50 IN NACL 0.9% W/PRES., (BENZYL ETOH 2%), B1-50MG, B2-5-PO4-5MG, B3-50MG, B5-50MG, B6-50MG/ML, 10ML Vials, MEDAUS PHARMACY

Published July 20, 2016 · Recall initiated: May 13, 2016

Summary

FDA records drug Class II recall D-1173-2016, published July 20, 2016 and initiated May 13, 2016. Recalling firm: Medaus, Inc.; Status: Terminated; Reported quantity: 4000 mL in Vials; Lot: Lot #: 151220-4, BUD: 06/17/16; Lot #: 160216-31, BUD: 08/14/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Medaus, Inc.
Distributor
U.S. Nationwide, Japan, and New Zealand.
Lot
Lot #: 151220-4, BUD: 06/17/16; Lot #: 160216-31, BUD: 08/14/16
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was B-COMPLEX 50 IN NACL 0.9% W/PRES., (BENZYL ETOH 2%), B1-50MG, B2-5-PO4-5MG, B3-50MG, B5-50MG, B6-50MG/ML, 10ML Vials, MEDAUS PHARMACY recalled?

Yes. FDA published recall D-1173-2016 on July 20, 2016. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail